Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
84 hedge funds and large institutions have $11.1M invested in Zomedica Corp. in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 19 closing their positions.
10% less capital invested
Capital invested by funds: $12.4M → $11.1M (-$1.22M)
13% less funds holding
Funds holding: 96 → 84 (-12)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$45.1K |
| 2 |
Jane Street
New York
|
+$25.1K |
| 3 |
JWM
Jackson Wealth Management
Lake Mary,
Florida
|
+$20K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$10.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$438K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$64.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$37.2K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$14.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.55K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWP
101
Triad Wealth Partners
Lawrence,
Kansas
| – | -$7 | -50 | Closed |
|
102
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$3 | -20 | Closed |
|
ZOM Hedge Fund Activity: Q3 2024 in Review
84 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2024, worth a combined $11.1M — down 9.9% from $12.4M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ZOM and 8 opened new positions — a net loss of 11 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Geode Capital Management, adding an estimated $45.1K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $438K sold.
- 84 institutional investors held Zomedica Corp. (ZOM) as of Q3 2024, down from 96 in Q2 2024.
- Funds reported $11.1M of Zomedica Corp. stock for Q3 2024, down 9.9% quarter-over-quarter.
- 8 funds opened new Zomedica Corp. positions in Q3 2024 and 19 closed out, a net change of -11 holders.
- The largest Zomedica Corp. buyer in Q3 2024 was Geode Capital Management, an estimated $45.1K added.
- The largest Zomedica Corp. seller in Q3 2024 was GSA Capital Partners, an estimated $438K sold.
Based on aggregated 13F filings for Q3 2024.